EPIEN Medical

Executive Summary

EPIEN Medical is a private medical technology company based in Minneapolis, USA, dedicated to addressing the global health challenge of restoring impaired tissue layers of the oral mucosa and submucosa. The company's proprietary solution leverages a groundbreaking debridement technology based on a chemical desiccation process, which aims to provide a non-invasive and effective method for treating oral mucosal conditions. By targeting a significant unmet need in oral healthcare, EPIEN Medical has the potential to improve patient outcomes and reduce healthcare costs. The company was founded in 2014 and operates in the small molecules category, though it remains in the early stages of development with no disclosed funding or revenue. If successful, EPIEN's technology could disrupt current treatment paradigms and capture a substantial market opportunity in oral wound care and related indications.

Upcoming Catalysts (preview)

• Q3 2026First-in-human clinical trial initiation40% success
• Q4 2026Strategic partnership with dental or pharmaceutical company30% success
• Q2 2026FDA pre-submission meeting or breakthrough device designation25% success